GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » EUDA Health Holdings Ltd (NAS:EUDA) » Definitions » ROE %

EUDA Health Holdings (EUDA Health Holdings) ROE % : 0.00% (As of Jun. 2023)


View and export this data going back to 2022. Start your Free Trial

What is EUDA Health Holdings ROE %?

ROE % is calculated as Net Income divided by its average Total Stockholders Equity over a certain period of time. EUDA Health Holdings's annualized net income for the quarter that ended in Jun. 2023 was $-24.40 Mil. EUDA Health Holdings's average Total Stockholders Equity over the quarter that ended in Jun. 2023 was $-5.97 Mil. Therefore, EUDA Health Holdings's annualized ROE % for the quarter that ended in Jun. 2023 was N/A%.

The historical rank and industry rank for EUDA Health Holdings's ROE % or its related term are showing as below:

During the past 4 years, EUDA Health Holdings's highest ROE % was Negative Equity%. The lowest was 0.00%. And the median was 5,540.63%.

EUDA's ROE % is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 4.32
* Ranked among companies with meaningful ROE % only.

EUDA Health Holdings ROE % Historical Data

The historical data trend for EUDA Health Holdings's ROE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

EUDA Health Holdings ROE % Chart

EUDA Health Holdings Annual Data
Trend Dec20 Dec21 Dec22 Dec23
ROE %
Negative Equity 1,081.25 - -

EUDA Health Holdings Quarterly Data
Dec20 Jun21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Dec23
ROE % Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Competitive Comparison of EUDA Health Holdings's ROE %

For the Health Information Services subindustry, EUDA Health Holdings's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


EUDA Health Holdings's ROE % Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, EUDA Health Holdings's ROE % distribution charts can be found below:

* The bar in red indicates where EUDA Health Holdings's ROE % falls into.



EUDA Health Holdings ROE % Calculation

EUDA Health Holdings's annualized ROE % for the fiscal year that ended in Dec. 2023 is calculated as

ROE %=Net Income (A: Dec. 2023 )/( (Total Stockholders Equity (A: Dec. 2022 )+Total Stockholders Equity (A: Dec. 2023 ))/ count )
=-10.039/( (-3.521+-7.499)/ 2 )
=-10.039/-5.51
=N/A %

EUDA Health Holdings's annualized ROE % for the quarter that ended in Jun. 2023 is calculated as

ROE %=Net Income (Q: Jun. 2023 )/( (Total Stockholders Equity (Q: Mar. 2023 )+Total Stockholders Equity (Q: Jun. 2023 ))/ count )
=-24.4/( (-5.954+-5.99)/ 2 )
=-24.4/-5.972
=N/A %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is four times the quarterly (Jun. 2023) net income data. ROE % is displayed in the 30-year financial page.

* Note that if the average Total Stockholders Equity is zero or negative, then ROE % would be considered meaningless and hence not be calculated.


EUDA Health Holdings  (NAS:EUDA) ROE % Explanation

ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.

The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:

ROE %(Q: Jun. 2023 )
=Net Income/Total Stockholders Equity
=-24.4/-5.972
=(Net Income / Revenue )*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(-24.4 / 4.428)*(4.428 / 13.7785)*(13.7785 / -5.972)
=Net Margin %*Asset Turnover*Equity Multiplier
=-551.04 %*0.3214*N/A
=ROA %*Equity Multiplier
=-177.1 %*N/A
=N/A %

With this breakdown, it is clear that if a company grows its Net Profit Margin, its Asset Turnover, or its Leverage, it can grow its ROE %.

The factors that affect a company's ROE % can also be illustrated with the five-step DuPont Analysis:

ROE %(Q: Jun. 2023 )
=Net Income/Total Stockholders Equity
=-24.4/-5.972
=(Net Income / Pre-Tax Income) * (Pre-Tax Income / Operating Income) * (Operating Income / Revenue) * (Revenue / Total Assets) * (Total Assets / Total Stockholders Equity)
= (-24.4 / -24.4) * (-24.4 / -7.732) * (-7.732 / 4.428) * (4.428 / 13.7785) * (13.7785 / -5.972)
= Tax Burden * Interest Burden * Operating Margin % * Asset Turnover * Equity Multiplier
= 1 * 3.1557 * -174.62 % * 0.3214 * N/A
=N/A %

Note: The net income data used here is four times the quarterly (Jun. 2023) net income data. The Revenue data used here is four times the quarterly (Jun. 2023) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net Income is used.

Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.


EUDA Health Holdings ROE % Related Terms

Thank you for viewing the detailed overview of EUDA Health Holdings's ROE % provided by GuruFocus.com. Please click on the following links to see related term pages.


EUDA Health Holdings (EUDA Health Holdings) Business Description

Traded in Other Exchanges
N/A
Address
1 Pemimpin Drive No. 12-07, One Pemimpin, Singapore, SGP, 576151
EUDA Health Holdings Ltd is a Singapore-based health technology company that operates a first-of-its-kind Southeast Asian digital healthcare ecosystem aimed at making healthcare affordable and accessible, The company's proprietary unified AI platform quickly assesses a patient's medical history, triages a condition, digitally connects patients with clinicians, and predicts optimal treatment outcomes. The company caters to all stages of care, including wellness and prevention, urgent care and emergencies, pre-existing conditions, and aftercare services. The company operates in two segments namely Medical services and property management services, out of which the company derives its maximum revenue from Medical services.
Executives
Kongyew Wong director C/O 6 EU TONG SEN STREET, #08-13, THE CENTRAL U0 059817
Chen Wei Wen Kelvin director, officer: CHIEF EXECUTIVE OFFICER C/O 1 PEMIMPIN DRIVE #12-07,, ONE PEMIMPIN SINGAPORE, SINGAPORE U0 576151
Alfred Lim director C/O 1 PEMIMPIN DRIVE #12-07, ONE PEMIMPI, SINGAPORE U0 576151
Kim Hing Chan director C/O 1 PEMIMPIN DRIVE #12-07, ONE PEMIMPIN SINGAPORE, SINGAPORE U0 576151
David Francis Capes director C/O 1 PEMIMPIN DRIVE #12-07, ONE PEMIMPIN SINGAPORE, SINGAPORE U0 576151
Daniel Tan officer: CHIEF TECHNOLOGY OFFICER C/O 1 PEMIMPIN DRIVE #12-07, ONE PEMIMPIN SINGAPORE, SINGAPORE U0 576151
Steven John Sobak officer: CHIEF FINANCIAL OFFICER C/O 1 PEMIMPIN DRIVE #12-07, ONE PEMIMPIN SINGAPORE, SINGAPORE U0 576151
Lim Thien Su Gerald director C/O 1 PEMIMPIN DRIVE #12-07, ONE PEMIMPI, SINGAPORE U0 576151
Tan Meng Dong (james) director, 10 percent owner, officer: Chief Executive Officer UNIT 2003 KINGKEY 100, TOWER B, 5015 SHENNAN EAST ROAD, LUOHU DISTRICT, SHENZHEN/GUANGDONG F4 518000
Alexander K. Arrow director PO BOX 3094, REDWOOD CITY CA 94064
Kwong Yeow Liew director RM 2313-2315, BLOCK B, ZHONGSHEN GARDEN, SHENZHEN F4 518101
Yap Guan Hong William director, officer: Chief Financial Officer 6 EU TONG SEN STREET, #08-13 THE CENTRAL, SINGAPORE U0 059817
Ajay Rajpal director 6 EU TONG SEN STREET, #08-13 THE CENTRAL, SINGAPORE U0 059817
8i Holdings 2 Pte Ltd 10 percent owner C/O 6 EU TONG SEN STREET, #08-13 THE CENTRAL, SINGAPORE U0 059817